Radiotherapy-induced brachial plexopathy (RIBP) is a rare but debilitating complication of breast cancer treatment. There is limited information available on the effective treatments for this condition. We present the case of a 68-year-old female with well-controlled schizophrenia and a history of breast cancer who was referred to our pain management clinic for dysesthesia in the left upper limb secondary to RIBP. The patient exhibited a remarkable response to intravenous (IV) lidocaine infusion, with near-complete resolution of her symptoms. This case highlights the potential of IV lidocaine infusion as a valuable component of a multimodal strategy for managing RIBP.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11452240 | PMC |
http://dx.doi.org/10.7759/cureus.68668 | DOI Listing |
Cureus
September 2024
Pain Medicine, Singapore General Hospital, Singapore, SGP.
J Surg Oncol
June 1997
Department of Surgery, The Netherlands Cancer Institute (Antoni van Leeuwenhoek ziekenhuis), Amsterdam, The Netherlands.
Background: Isolated limb perfusion (ILP) with tumor necrosis factor alpha (TNF alpha) +/-interferon gamma (IFN gamma) and melphalan in patients with primarily irresectable soft tissue sarcoma is promising in terms of tumor regression and limb salvage. However, the feasibility of radiotherapy in combination with this treatment modality has not been established.
Methods: Fifteen patients with irresectable soft tissue tumors of the limb underwent ILP with TNF alpha, +/-IFN gamma, and melphalan.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!